Vir Biotechnology Inc (VIR)
8.23
+0.60
(+7.86%)
USD |
NASDAQ |
Apr 26, 16:00
8.21
-0.02
(-0.24%)
After-Hours: 20:00
Vir Biotechnology Price to Book Value: 0.6988 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 26, 2024 | 0.6988 |
April 25, 2024 | 0.6479 |
April 24, 2024 | 0.6827 |
April 23, 2024 | 0.6903 |
April 22, 2024 | 0.6878 |
April 19, 2024 | 0.6751 |
April 18, 2024 | 0.6759 |
April 17, 2024 | 0.7005 |
April 16, 2024 | 0.7099 |
April 15, 2024 | 0.7277 |
April 12, 2024 | 0.7617 |
April 11, 2024 | 0.7846 |
April 10, 2024 | 0.7719 |
April 09, 2024 | 0.8092 |
April 08, 2024 | 0.8058 |
April 05, 2024 | 0.7931 |
April 04, 2024 | 0.8041 |
April 03, 2024 | 0.8228 |
April 02, 2024 | 0.8169 |
April 01, 2024 | 0.8661 |
March 28, 2024 | 0.8602 |
March 27, 2024 | 0.8576 |
March 26, 2024 | 0.8466 |
March 25, 2024 | 0.8491 |
March 22, 2024 | 0.8534 |
Date | Value |
---|---|
March 21, 2024 | 0.8568 |
March 20, 2024 | 0.8636 |
March 19, 2024 | 0.8491 |
March 18, 2024 | 0.9069 |
March 15, 2024 | 0.9137 |
March 14, 2024 | 0.8933 |
March 13, 2024 | 0.9298 |
March 12, 2024 | 0.9111 |
March 11, 2024 | 0.968 |
March 08, 2024 | 0.9646 |
March 07, 2024 | 0.9561 |
March 06, 2024 | 0.9273 |
March 05, 2024 | 0.9239 |
March 04, 2024 | 0.9502 |
March 01, 2024 | 0.9544 |
February 29, 2024 | 0.9544 |
February 28, 2024 | 0.985 |
February 27, 2024 | 0.9706 |
February 26, 2024 | 1.010 |
February 23, 2024 | 0.9791 |
February 22, 2024 | 0.8746 |
February 21, 2024 | 0.8585 |
February 20, 2024 | 0.8687 |
February 16, 2024 | 0.8704 |
February 15, 2024 | 0.8738 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6232
Minimum
Oct 27 2023
15.29
Maximum
Feb 27 2020
4.485
Average
2.504
Median
Price to Book Value Benchmarks
Vertex Pharmaceuticals Inc | 5.840 |
Vistagen Therapeutics Inc | 1.041 |
Immuneering Corp | 0.4813 |
SeaStar Medical Holding Corp | -- |
NovaBay Pharmaceuticals Inc | 1.739 |
Price to Book Value Related Metrics
PS Ratio | 27.95 |
Price | 8.23 |
Earnings Yield | -55.77% |
Market Cap | 1.111B |